Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Yangzhou
Clinical trial register · China

Clinical Trials in Yangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Yangzhou 23
Narrow the registerReset
Recruitment status
Phase
Site location
Yangzhou23
All 1 locations
Target enrolment
to

Trials with a site in Yangzhou

23 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
NCT07811687Liver Cirrhosis, HCC - Hepatocellular Carcinoma, Hypersplenism
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-08-02
Not yet open
Northern Jiangsu People's Hospital
Observational
140
Yangzhou
2026-06-01
Not yet open
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
NCT07588334Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07588373Cirrhosis, Splenectomy; Status, Hypersplenism, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07585773Cirrhosis, Splenectomy; Status, Hypersplenism, Kidney Function Issue
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Recruiting
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
NCT07461545Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2026-04-01
Recruiting
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
NCT07461532Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2026-04-01
Recruiting
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
NCT07462091Cirrhosis, Hypersplenism, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
15
Yangzhou
2026-03-25
Recruiting
Northern Jiangsu People's Hospital
Phase 4
336
Yangzhou
2026-03-02
Recruiting
Northern Jiangsu People's Hospital
Observational
50
Yangzhou
2026-01-07
Recruiting
Northern Jiangsu People's Hospital
Phase 2
30
Yangzhou
2025-11-01
Recruiting
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
NCT07205471Cirrhoses, Liver, Splenectomy; Status, Partial
Northern Jiangsu People's Hospital
Not applicable
30
Yangzhou
2025-09-24
Recruiting
Northern Jiangsu People's Hospital
Phase 2
30
Yangzhou
2025-09-01
Recruiting
Northern Jiangsu People's Hospital
Phase 2
20
Yangzhou
2025-08-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
300
Yangzhou
2025-08-01
Recruiting
Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen
NCT07053605Splenic Artery Aneurysm, Immune Function, Hemodynamics
Northern Jiangsu People's Hospital
Not applicable
10
Yangzhou
2025-06-23
Active, closed
Northern Jiangsu People's Hospital
Not applicable
190
Yangzhou
2025-03-16
Active, closed
Northern Jiangsu People's Hospital
Not applicable
376
Yangzhou
2024-10-10
Recruiting
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
NCT05433467Cirrhosis, Liver, Hepatocellular Carcinoma
Northern Jiangsu People's Hospital
Not applicable
5
Yangzhou
2022-05-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Recruiting
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/yangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Yangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Yangzhou?

16 of the 23 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 5 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yangzhou), 23 studies
PhaseStudiesRecruitingShare
Not applicable131056.5%
Observational6226.1%
Phase 23313%
Phase 4114.3%

Most active sponsors

Lead sponsors with the most studies (Yangzhou)
Lead sponsorStudiesRecruiting
Northern Jiangsu People's Hospital2316
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.